Marie‐Emmanuelle Riviere

Author

Also Known As

M RIVIERE, M Riviere, M. Riviere, M.E. Riviere, Marie-Emmanuelle Riviere, Marie-Emmanuelle Rivière, Marie‐Emmanuelle Riviere, Marie‐emmanuelle Riviere, Riviere M

Publications

672

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)Banner Alzheimer’s Institute Alzheimer's Association Novartis (United States)Tris Pharma (United States)

About

Marie‐Emmanuelle Riviere is an author at Novartis (Switzerland) specializing in medicine, neurology, and neurodegenerative diseases.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	185
2	Neurology	3	3	185
3	Health Sciences	1	1	23
4	Epidemiology	1	1	23
5	Immunology	1	1	23

Marie‐Emmanuelle Riviere

Publications

415

Citations

H-Index

Page 1

	Year	Citations
Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study Rik Vandenberghe, Marie‐Emmanuelle Riviere, Angelika Caputo, Alzheimer s & Dementia Translational Research & Clinical Interventions	2016	133
Rufinamide: a double-blind, placebo-controlled proof of principle trial in patients with epilepsy Sven Pålhagen, R. Canger, Olaf Henriksen, Epilepsy Research PsychiatryPrinciple TrialPsychotropic MedicationNeuropharmacologyPharmacotherapy	2001	127
Alzheimer's Prevention Initiative Generation Program: Development of an <i>APOE</i> genetic counseling and disclosure process in the context of clinical trials Carolyn Langlois, Angela R. Bradbury, Elisabeth McCarty Wood, Alzheimer s & Dementia Translational Research & Clinical Interventions	2019	49
The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease Jessica B. Langbaum, Noel Ellison, Angelika Caputo, Alzheimer s Research & Therapy	2020	36
THE ALZHEIMER’S PREVENTION INITIATIVE GENERATION PROGRAM: EVALUATING CNP520 EFFICACY IN THE PREVENTION OF ALZHEIMER’S DISEASE Cristina López López, Antonella Caputo, F. Liu, The Journal of Prevention of Alzheimer s Disease Neurodegenerative DiseasesAlzheimer's DiseaseBrain HealthTreatment EvaluationNeurology	2017	35
Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired <i>APOE</i> ε4 homozygotes Marie‐Emmanuelle Riviere, Jessica B. Langbaum, Raymond Scott Turner, Alzheimer s & Dementia Active ImmunotherapyImmunologyNeurochemical BiomarkersPet MeasurementsGeriatric Neurology	2023	23
Reversibility of cognitive worsening observed with BACE inhibitor umibecestat in the Alzheimer's Prevention Initiative (API) Generation Studies Pierre N. Tariot, Marie‐Emmanuelle Riviere, Stephen Salloway, Alzheimer s & Dementia	2024	12

Page 1